Trial Details
TERMINATEDBasic Information
| Clinical ID | c943 |
|---|---|
| Identifier | NCT05784129 |
| Trial Title | A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Guselkumab|DRUG: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-02-21 |
|---|---|
| Primary Completion Date | 2023-09-29 |
| Completion Date | 2023-10-10 |